Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Docetaxel+Cisplatin and 5-fluorouracil (TPF) Followed by Radiotherapy+Concomitant Chemo or Cetuximab Versus Radiotherapy+Concomitant Chemo or Cetuximab in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. A Randomized Phase III Factorial Study.

NCT01086826 is registered in ClinicalTrials.gov with Associazione Volontari Pazienti Oncologici as lead sponsor.

NCT NCT01086826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Docetaxel+Cisplatin and 5-fluorouracil (TPF) Followed by Radiotherapy+Concomitant Chemo or Cetuximab Versus Radiotherapy+Concomitant Chemo or Cetuximab in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. A Randomized Phase III Factorial Study.
Lead sponsor
Associazione Volontari Pazienti Oncologici
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2014
Enrollment
320 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma